Printer Friendly

EDITEK, INC. BEGINS SHIPPING VERDICT OPIATES ONE-STEP TESTS

 BURLINGTON, N.C., May 10 /PRNewswire/ -- EDITEK, Inc. (AMEX: EDI.EC) reported today that it has completed product development and begun shipment of the VERDICT Opiates one-step tests. The company began shipment of its first one-step test, VERDICT Cocaine, in February. The VERDICT family of one-step assays utilize the patented technology possessed by EDITEK including patents covering, among other things, the device and methodology for the performance of one-step assays.
 EDITEK continues to build on its leadership in the on-site drug testing marketplace. The company obtained the first FDA pre-market clearance for an on-site substance abuse immunoassay in February 1987. The EZ-SCREEN family of on-site drug assays are recognized for their high level of sensitivity in detecting abused substances while simultaneously offering "on board" positive and negative quality control procedures. The new VERDICT family of substance abuse assays provides the patented convenience of one-step sample additions and observation of the test result. The market launch of the VERDICT Opiates one-step test will soon be followed by the VERDICT Cannabinoids (marijuana) one-step test. The use of marijuana, cocaine and opiates (heroin) account for more than 95 percent of abused substances.
 EDITEK, Inc. is an emerging, biodiagnostic company with patented technology for the performance of rapid, on-site assays including one- step assays. The company currently sells products for the human/clinical, drugs of abuse and agridiagnostics/food safety testing markets. EDITEK also has research, development and supply agreements with Farnam Companies and the United States Department of Defense for veterinary diagnostics and tests for biological substances respectively.
 -0- 5/10/93
 /CONTACT: Peter Heath, Vice President Finance and Chief Financial Officer, EDITEK, Inc., 919-226-6311/
 (EDI)


CO: EDITEK, Inc. ST: North Carolina IN: CHM SU: PDT

SB -- CH003 -- 6477 05/10/93 12:06 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 10, 1993
Words:292
Previous Article:THE WILLIAMS COMPANIES INC. DECLARES SECOND-QUARTER DIVIDENDS
Next Article:THREE DUKE POWER EMPLOYEES WIN COMPANY'S HIGHEST AWARD
Topics:


Related Articles
EDITEK, INC. ANNOUNCES THIRD QUARTER RESULTS
EDITEK SUES DISEASE DETECTION INTERNATIONAL RELATIVE TO A LICENSE AGREEMENT TERMINATED NEARLY FIVE YEARS AGO
EDITEK BEGINS MARKETING AND DISTRIBUTION OF VERDICT COCAINE ONE-STEP DRUG TEST
EDITEK WINS PRELIMINARY INJUNCTION ROUND IN COURT
EDITEK ANNOUNCES INCREASED REVENUES, STRONGER CASH POSITION AND SIGNIFICANT ACHIEVEMENTS FOR FISCAL YEAR 1992
EDITEK, INC., RECEIVES NEW PATENT
U.S. ALCOHOL TESTING SUBMITS NEW 510(k) APPLICATION TO FDA
EDITEK RECEIVES SECOND VERDICT FDA PRE-MARKET CLEARANCE
EDITEK LAUNCHES EZ-SCREEN(R) PROFILE(TM) DRUGS OF ABUSE PRODUCT
EDITEK Receives FDA Pre-Market Clearance For EZ-SCREEN(R) PROFILE(TM) Drugs of Abuse Product

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters